Wellgistics Health, Inc.

Wellgistics Health, Inc.

NNASDAQ:WGRX
3.52
USD
+0.81
(+29.89%)
-44.78EPS
11.51MMarket Cap

Total Valuation

USD

As of March 31, 2026, Wellgistics Health, Inc. carries a market capitalization of 11.51M, placing it among publicly traded companies globally. Its enterprise value stands at 40.37M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap11.51M
Enterprise Value40.37M

Share Statistics

As of March 31, 2026, Wellgistics Health, Inc. has 2.39M shares outstanding.

Shares Outstanding2.39M

Valuation Ratios

These figures are as of March 31, 2026. The price-to-sales ratio is 0.59, and the price-to-book ratio stands at -0.76.

PS Ratio0.59
PB Ratio-0.76
P/TBV Ratio-0.28
P/FCF Ratio-0.62
P/OCF Ratio-0.64

Enterprise Valuation

These figures are as of March 31, 2026. The EV/Sales ratio of 2.88 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 40.37M versus a market cap of 11.51M, with the gap driven by net debt and cash on the balance sheet.

EV / Sales2.88

Financial Position

As of March 31, 2026, Wellgistics Health, Inc. maintains a current ratio of 0.09, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -191.96, indicating conservative leverage, while an interest coverage ratio of -11.81 demonstrates limited ability to service its debt obligations.

Current Ratio0.09
Quick Ratio0.03
Debt / Equity-191.96
Debt / EBITDA-0.44
Interest Coverage-11.81

Financial Efficiency

These figures cover the twelve months ended March 31, 2026. Return on assets (ROA) is negative at -173.68, reflecting losses generated across the asset base. Inventory turnover of 3.67 indicates how many times Wellgistics Health, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Assets (ROA)-173.68
Inventory Turnover3.67

Stock Price Statistics

USD

As of the close on July 21, 2026, Wellgistics Health, Inc.'s stock has declined approximately 94.03% over the past 52 weeks. The 50-day moving average sits at 3.80, while the 200-day moving average is 15.08.

52-Week Price Change-94.03%
50-Day Moving Average3.80
200-Day Moving Average15.08

Income Statement

USD

Over the twelve months ended March 31, 2026, Wellgistics Health, Inc. generated 14.03M in revenue and converted that into -76.59M in net income, yielding earnings per share of -44.78. EBITDA reached -65.65M, while operating income came in at -55.86M.

Revenue14.03M
Gross Profit-6.95M
Operating Income-55.86M
Pretax Income-76.59M
Net Income-76.59M
EBITDA-65.65M
EBIT-68.42M
Earnings Per Share (EPS)-44.78

Balance Sheet

USD

As of March 31, 2026, Wellgistics Health, Inc. holds 51,730.00 in cash and equivalents against 28.91M in total debt, resulting in a net debt position of 27.90M. Total book value stands at -15.06M, with working capital of -29.44M providing operational flexibility.

Cash & Cash Equivalents51,730.00
Total Debt28.91M
Net Debt27.90M
Equity (Book Value)-15.06M
Book Value Per Share-6.31
Working Capital-29.44M

Cash Flow

USD

Wellgistics Health, Inc. produced -12.92M in operating cash flow over the twelve months ended March 31, 2026. After subtracting -337,024.00 in capital expenditures, free cash flow totaled -13.26M - equivalent to -7.75 per share.

Operating Cash Flow-12.92M
Capital Expenditures-337,024.00
Free Cash Flow-13.26M
FCF Per Share-7.75

Margins

Over the twelve months ended March 31, 2026, Wellgistics Health, Inc. posted a gross margin of -49.51, reflecting its pricing power and cost economics. The operating margin of -398.05 and net profit margin of -545.72 provide insight into operational efficiency.

Gross Margin-49.51
Operating Margin-398.05
Pretax Margin-545.72
Profit Margin-545.72
EBITDA Margin-467.80

Dividends & Yields

These figures cover the twelve months ended March 31, 2026. Free cash flow yield is negative at -160.81: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -97.91, meaning Wellgistics Health, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-97.91
FCF Yield-160.81

Stock Splits

Wellgistics Health, Inc.'s most recent stock split took place on May 26, 2026 with a 50:1 split ratio.

Last Split Date5/26/2026
Split Ratio50:1

Scores

As of March 31, 2026, Wellgistics Health, Inc. has an Altman Z-Score of -95.39, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-95.39